@prefix this: . @prefix sub: . @prefix np: . @prefix rdf: . @prefix xsd: . @prefix rdfs: . @prefix ns2: . @prefix ns1: . @prefix prov: . @prefix ns3: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { ns1:reduce . } sub:provenance { sub:assertion prov:generatedAtTime "2021-12-16T19:43:59.589531"^^xsd:dateTime; prov:wasGeneratedBy "S&T TWOC project version 2" . sub:version prov:value "2"^^xsd:integer . rdf:OBJECT rdfs:label "morbidity" . rdf:OBJECT-POSITION rdfs:label "223"^^xsd:integer . rdf:PREDICATE rdfs:label "reduce" . rdf:PREDICATE-POSITION rdfs:label "[216]" . rdf:SUBJECT rdfs:label "adjunctive treatment of established ARDS caused by the coronavirus disease 2019 ( COVID)-19 ) with intravenous dexamethasone" . rdf:SUBJECT-POSITION rdfs:label "-1"^^xsd:integer . rdfs:ABSTRACT-UID ns2:50 "e583sv4c" . rdfs:SENTENCE rdfs:label "We postulated that adjunctive treatment of established ARDS caused by the coronavirus disease 2019 (COVID)-19) with intravenous dexamethasone might change the pulmonary and systemic inflammatory response and thereby reduce morbidity, leading to a decrease in duration of mechanical ventilation and in mortality." . rdfs:TRIPLE-UID ns3:e583sv4c-TRIPLE-ABSTRACT-4 "e583sv4c-TRIPLE-ABSTRACT-4" . rdfs:label "morbidity" . rdfs:label "adjunctive treatment" . } sub:pubInfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB"; npx:hasSignature "XN9RmFiK7ApyIVT2KrxTg5qaLHXn9eWzCCd2h8WbhDoLjJFK2QZ+bQYvJtuCld1B8EdPSSx7dHT1NySXmuSH2bki5ureqx9Y8b1jgx4u3SVwX3HahbAlb3lTnLTzah9XMLR0Lr73GKuMyQEib9O12EranXLm7L82TPsvPT+cVe4="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2021-12-16T19:43:59.589531"^^xsd:dateTime; prov:wasAttributedTo . }